 Your new post is loading...
 Your new post is loading...
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:43 AM
|
A new scientific review from Poland discusses irreparable harm done by vaccines. This review addresses the issue in terms of adverse effects, immune system effects, neurological symptoms following vaccination, and a history of vaccines demonstrating little benefit. It centers mostly on studies not often referenced in the western world, providing fresh and broad-ranging information. An honest reading of the study can leave little doubt that harm done may be extensive and often permanent.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:41 AM
|
Vaccines pro and con, the vaccination critical website all about vaccines , vaccine reactions, vaccine injuries, vaccine damages and vaccine dangers
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:40 AM
|
Yeast is associated with the staff of life, bread—not to mention being the basis of pleasure-inducing beer. So why should we be concerned about its presence in a large number of vaccines?
A new study reveals that injecting yeast may be the cause of the autoimmune disease epidemic, which is devastating the lives of millions.
The specific part of S. cerevisiae that’s of concern is mannan, which is found in the cell walls of yeasts and also in mammalian glycoproteins. These glycoproteins are found in cell walls, connective tissues like collagen, gastrointestinal mucous secretions, and blood plasma. They perform many functions.
Obviously, if the immune system goes on the attack against mannan, it can be devastating. Yet, that appears to be happening in many autoimmune diseases.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:39 AM
|
The pharmaceutical industry has “mobilised” an army of patient groups to lobby against plans to force companies to publish secret documents on drugs trials. Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. While some companies have agreed to share data more freely, the industry has broadly resisted the moves. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:33 AM
|
Safety testing on the INTER-relationship of vaccines has NEVER been done.
The vaccines on the schedule have never been tested together.
Neither the CDC nor FDA can prove that the current schedule is safe.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:32 AM
|
“Some physicians would stand by and see their patient die rather than use ascorbic acid because in their finite minds it exists only as a vitamin.” (F. R. Klenner, MD) ‘It might be interesting to learn how poliomyelitis was treated in Reidsville, N.C., during the 1948 epidemic. In the past seven years, virus infections have been treated and cured in a period of seventy-two hours by the employment of massive frequent injections of ascorbic acid, or vitamin C. I believe that if vitamin C in these massive doses - 6,000 to 20,000 mg in a twenty-four hour period - is given to these patients with poliomyelitis none will be paralyzed and there will be no further maiming or epidemics of poliomyelitis.’ Levy concludes: “The four doctors who commented after Klenner did not have anything to say about his assertions.”
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:26 AM
|
The US Government is well aware Cannabis has medicinal properties. How could they not? It's been used as a medicine for at least the past 10,000 years. Even in America, Cannabis was used as a medicine for over 100 years. It was in over a hundred over the counter medicines for a wide range of reasons. In '72 Richard Nixon wanted a larger budget for his war on drugs. He thought that if he proved Cannabis caused lung cancer like cigarettes do, he would get the support he needed. He gave the Medical College of Virginia 2 years to do a study on the effects of THC on the body. In '74 the study was completed. It turns out, THC when ingested in highly concentrated forms (such as eating Cannabis oil) will attack any mutated cells in your body while strengthening and rejuvenating the healthy cells. They found the PERFECT cure for Cancer. It worked fast, it worked well, it worked on many different forms of Cancer in ALL stages and it had ZERO harmful side effects. When Richard Nixon saw the results of the study he was FURIOUS...
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Cancer Survivorship
August 18, 2013 2:00 AM
|
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:29 PM
|
Last month, 130 doctors, nurses, development workers, techies, government officials, and academics from 35 countries joined us on an exciting four-week journey through the latest developments in mHealth. Three observations/trends emerged during the course: Mobile data collection most discussed! Mobile data collection, management and analysis gained significant attention in the course forums. We were thrilled to be joined by Yaw Onokwa, one of the founders of Open Data Kit and Jeremy of CommCare who provided students with live demos of their respective software packages and shared a number of insights and best practices for developing surveys, acquiring and managing users, scaling data projects and more. The always-engaging Alain Labrique (Johns Hopkins University) joined us for a fantastic session on the continuum of care that touched on his exciting work in Bangladesh and the importance of investing in the evidence base. The importance of human centered design (HCD): Human-centered design also featured prominently throughout the four weeks. Isaac Holman (co-founder of Medic Mobile) led participants through an exercise in drawing/mapping a health ecosystem based on HCD principles. Design experts Erica Kochi (UNICEF Innovation) and Robert Fabricant (Frog Design) shared a wealth of insights from their experiences in successfully launching and sustaining mHealth projects in a number of countries. For many of these world-class practitioners, this was the first time they had ever presented in an online course like this. Fewer pilots + design for scale: After the New York Times featured an article last spring entitled The Benefits of Mobile Health on Hold there was certainly a lot of room for debate and critical discussion about “pilotitis”. Patty Mechael noted that one trend she has observed in last year is fewer organizations are starting pilots more are focused on designing for scale from the onset of a project. And finally, Gustav Praekelt shared the amazing work his foundation has undertaken to team up with leading private sector entities in South Africa to achieve scale (1 million+) in fighting HIV and preparing mothers for childbirth. Three highlights from the course: Techies + Healthies: We featured a TEDx Talk by Josh Nesbit titled, “Techies + Healthies”, which prompted an insightful discussion about the need to promote more engagement between practitioners from both fields. We also asked participants to reflect on their own orientation on the healthie – techie spectrum. Zombies, Zombies, Zombies: What would a TechChange course be without a Zombie Apocalypse. This time, participants had to respond to an impending zombie invasion and practice gathering vital health and preparedness data using tools like Magpi, FrontlineSMS, CommCare formhub, OpenDataKit and more. What a Map! We asked participants to describe the health systems in their own countries and then crowdsourced an interactive Google Map of everyone’s responses. I personally learned a tremendous amount about the challenges and opportunities that exist in other countries through this visualization and am excited to do more of these kinds of activities in future courses.
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:07 PM
|
There’s no question the gaming world has influenced recent developments in healthcare. Avatars, for example, have been entering the realms of health insurance exchanges, patient adherence and clinical trial collaboration. Actual games have been developed to help doctors identify symptoms of post-traumatic stress disorder, improve vaccine education, and help young doctors and nurses improve their communication skills with patients. But how about holograms?
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:04 PM
|
A study conducted by the Center for Connected Health, a division of Partners HealthCare, showed wireless mobile technologies positively impact patient engagement and can be more effective than modem-based devices. The study was published in the Journal of Diabetes Science and Technology in May. Patients using wireless devices recorded on average three measurements every five days and patients using modem-based devices on average recorded one measurement every five days. When uploading data, patients with wireless-enabled devices uploaded their information on average twice every five days and those with modem-enabled devices uploaded once every 100 days. While the time it took patients to first upload their data was lower for the patients in the wireless-based device group at four days versus seven days, the time to first measurement didn’t differ much.
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:02 PM
|
As the DPC market has matured, off-the-shelf software, engineered for the unique requirements of DPC, has emerged. Not only is this lowering the cost to obtain functional software, but it is opening up new means of delivering care. As traditional practices evolve to accountable models, these requirements will be the same. DPC practices simply are the early adopters. The following are facets of the technology changes and their implications on DPC: Cloud-based Software-as-a-Service: As low overhead operations, DPC practices not only demand the price advantages that come with cloud-based services, they want the simplicity of not having to set up and maintain server software as well as having to update individual PCs that most healthIT still requires. Nimble software: The practice patterns are continuing to evolve particularly as new technologies open up care models that weren’t possible before. Consequently, the ability to easily modify workflow, templates, etc is vital. Mobile devices: Both patients and doctors have mobile devices wherever they are. DPC practices, as inherently customer focused organizations, naturally want to deliver convenience to their patients. One DPC practice shared how they haven’t seen a patient with shingles in person in years. Instead of the hassle of scheduling an appointment (often taking days to get in), they can take a picture of the symptoms with their mobile device and send it to their doctor right away. Assuming it is shingles, the doctor can call in a prescription and save everyone time and money.Biometric devices: There is an explosion of personal biometric devices. Increasingly, patients are buying them or providers are buying them on behalf of patients with chronic conditions.
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:00 PM
|
If there’s one thing we can always count on in the medical device world, it’s the steady beat of progress. We look for the big idea that will save lives, make doctors’ jobs easier and the medical field more efficient — thus saving costs. As designers, we keep our eyes on innovations in the medical device world. Here are three trends that are making an impact. Making medical devices smaller and portable Access to effective care often requires medical devices which are smaller, lighter and more portable. In order to go big, we need to think small. Interestingly, this trend is prevalent in both resource poor and resource rich healthcare systems
The drive towards earlier and more accurate diagnosis Current cancer detection and monitoring methods can be extremely invasive or poorly targeted, resulting in low treatment efficacy and unpleasant side effects
Using data for prevention There is a growing desire for medical devices — including those that are wearable — to track and monitor personal health. There are countless smart phone apps that track health-related issues, such as restful sleep, exercise, and diet. The current trend is towards devices that support and tap into our increasingly endless desire for more information.
Via nrip
|
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:42 AM
|
In a 5-4 vote, the US Supreme Court struck down a lower court’s ruling and award for the victim of a pharmaceutical drug’s adverse reaction. According to the victim and the state courts, the drug caused a flesh-eating side effect that left the patient permanently disfigured over most of her body. The adverse reaction was hidden by the drug maker and later forced to be included on all warning labels. But the highest court in the land ruled that the victim had no legal grounds to sue the corporation because its drugs are exempt from lawsuits. Justices cited the fact that all generic drugs and their manufacturers, some 80% of all drugs consumed in the United States, are exempt from liability for side effects, mislabeling or virtually any other negative reactions caused by their drugs. In short, the Court ruled that the FDA has ultimate authority over pharmaceuticals in the US. And if the FDA says a drug is safe, that takes precedence over actual facts, real victims and any and all adverse reactions.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:40 AM
|
A groundbreaking new clinical study proves that the turmeric extract known as curcumin is at least as effective as Prozac in treating serious depression. The research was performed at the Department of Pharmacology, Government Medical College, Bhavnagar, Gujarat, India, and involved patients diagnosed with major depressive disorder (MDD). The objective of the trial was to compare the efficacy and safety of curcumin with fluoxetine (Prozac) in 60 patients diagnosed with MDD. Subjects were randomized to receive either a six week treatment with fluoxetine (20 mg) and curcumin (1000 mg) individually or their combination. We observed that curcumin was well tolerated by all the patients. The proportion of responders as measured by the HAM-D17 scale was higher in the combination group (77.8%) than in the fluoxetine [Prozac] (64.7%) and the curcumin (62.5%) groups; however, these data were not statistically significant (P = 0.58).
Interestingly, the mean change in HAM-D17 score at the end of six weeks was comparable in all three groups (P = 0.77). This study provides first clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with MDD without concurrent suicidal ideation or other psychotic disorders.
If the results of this relatively small trial are applicable to a wider population, this is truly groundbreaking news.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:40 AM
|
There are big differences between natural genetic modification done by organisms themselves and the artificial genetic modification done by ‘genetic engineers’ in the lab. Natural genetic modification is precise and predictable. It happens in the right place, at the right time without damaging the genome, and as appropriate to the organisms as a whole in relation to its environment. In contrast, artificial genetic modification is crude, imprecise, unpredictable and uncontrollable. The artificially created GM constructs have to be smuggled in by (disarmed) pathogenic bacteria and viruses that infect the cells, or otherwise forced into the cells by gene guns or electric shocks. The artificial constructs get scrambled in the process and could land anywhere in the genome, scrambling and damaging the genome in the process. Aggressive promoters are used essentially to force foreign genes to be expressed out of context.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:36 AM
|
Learning how to be healthy is not easy. In this article you'll discover practical and down to earth tips on how to get started, so come right in.
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:32 AM
|
Two landmark events – a government concession in the US Vaccine Court, and a groundbreaking scientific paper – confirm that physician, scientist, and Autism Media Channel [AMC] Director, Dr. Andrew Wakefield, and the parents were right all along. In a recently published December 13, 2012 vaccine court ruling, hundreds of thousands of dollars were awarded to Ryan Mojabi, [i] whose parents described how “MMR vaccinations,” caused a “severe and debilitating injury to his brain, diagnosed as Autism Spectrum Disorder (‘ASD’).” Later the same month, the government suffered a second major defeat when young Emily Moller from Houston won compensation following vaccine-related brain injury that, once again, involved MMR and resulted in autism. The cases follow similar successful petitions in the Italian and US courts
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:30 AM
|
In his day, Jungeblut was justly regarded as an important player in polio research. While recent revisionist history of the fight against polio has generally downplayed his contribution to the crusade, it has totally sidestepped what was arguably his most important discovery: that ascorbate is prevention and cure for polio. Amazingly, Jungeblut first published this idea in 1935. His research on ascorbate was sweeping and profound, extending well beyond the topic of polio. In 1935, he also had shown that vitamin C inactivated diphtheria toxin. By 1937, Jungeblut demonstrated that ascorbate inactivated tetanus toxin. John T. A. Ely, PhD, writes: "In the 1930's, the remarkable Claus W. Jungeblut, MD . . . first reported that ascorbic acid in concentrations, attainable in humans by a high intake, could inactivate and or protect against numerous viral and bacterial pathogens and their toxins. These include the polio, hepatitis and herpes viruses. . . One of (Jungeblut's) earliest research findings was ascorbic acid's ability to neutralize and render harmless many bacterial toxins, such as tetanus, diphtheria, and staph toxins."
Via Sepp Hasslberger
|
Rescooped by
shelbylaneMD
from Health Supreme
August 18, 2013 11:26 AM
|
On July 29, 2013, the Supreme Court of Israel ruled that new regulations require Israel to stop adding fluoride chemicals into public water supplies in one year, reports the Fluoride Action Network (FAN). Izun Hozer Association for Dissemination of Health Education and Yaacov Gurman petitioned Israel's highest court, November 12, 2012, demanding that the Ministry of Health order the cessation of fluoridation because it presents health dangers and its benefits are no longer widely accepted. A 1974 regulation mandated fluoridation throughout Israel. But in April 2013, the Minister of Health, Yael German, created a new regulation removing that mandate. "It must be known to you that fluoridation can cause harm to the health of the chronically ill," including "people who suffer from thyroid problems," German wrote in a letter addressed to doctors opposed to ending fluoridation.
Via Sepp Hasslberger
|
Scooped by
shelbylaneMD
August 17, 2013 2:12 PM
|
Insightful coverage of healthcare innovation
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:08 PM
|
If your brain is swelling, either due to infection or physical injury, you're going to need these Headsense cranial monitors more than you need another hole in your head. The fluids in your cranial cavity exerts a specific force on the brain and skull, known as your intracranial pressure (ICP), and help keep your brain from sloshing around in there. Sometimes, however, your ICP can rise due to a knock on the head or a disease like meningoencephalitis, causing the brain to squish against the skull and cut off blood flow to the afflicted regions (effectively causing you to stroke out) Headsense is an Israeli startup that has developed a pair of disposable ear buds that monitor ICP using sound waves rather than drill bits. The buds will sound a series of low frequency tones on one side of your head and record the sounds as they pass through your skull to the other bud. By measuring the distortions to that tone caused by blood flow variations, the system can calculate your ICP in seconds. “It’s kind of like a pipe organ,” Weinberg says. “A pipe organ has pipes with different diameter that produce sounds with different pitch. This is exactly the same case.”
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:04 PM
|
Google GOOG +1.25% Glass has made its way into healthcare. Its use in theoperating room and in medical education has been profiled here. Yet the magic of Glass will be found in the applications that can make this “technology” into real-world solutions for health and medicine. It’s a bit like the smart phone and how its realization is a function of the countless apps that bring the device to life. Christian Assad, MD has taken the next step with Glass and developing a practical app that can turn Glass into a real life-saver. He recently profiles this application on his blog and I believe it’s an important turn of events that showcase just how technology can be applied to medicine and public health issues. Here’s how it presents the concept in his blog–Google Glass and augmented CPR: THE CPRGLASS SCENARIO
1) Person walking, witnesses someone passing out (syncope)
2) Individual says “OK GLASS, CPRGLASS” A) Instructions appear ABC (Assess Airway, Breathing and Circulation) B) “OK GLASS, No Pulse!” (An algorithm developed by Hao-Yu Wu et al at MIT demonstrate how a normal camera can detect a pulse in a person with strong accuracy.) We are looking incorporate such algorithm aka (which will be open source) ”Eulerian video magnification” to CPRGLASS for 2 reasons;
1) Will help as an innovative method to assess if the compressions are adequate
2) Will be able to tell us if patient has regained pulse if we stop compressions, possibly, instead of even having to look for a pulse
Via nrip
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:03 PM
|
|
Rescooped by
shelbylaneMD
from healthcare technology
August 17, 2013 1:02 PM
|
As the DPC market has matured, off-the-shelf software, engineered for the unique requirements of DPC, has emerged. Not only is this lowering the cost to obtain functional software, but it is opening up new means of delivering care. As traditional practices evolve to accountable models, these requirements will be the same. DPC practices simply are the early adopters. The following are facets of the technology changes and their implications on DPC: Cloud-based Software-as-a-Service: As low overhead operations, DPC practices not only demand the price advantages that come with cloud-based services, they want the simplicity of not having to set up and maintain server software as well as having to update individual PCs that most healthIT still requires. Nimble software: The practice patterns are continuing to evolve particularly as new technologies open up care models that weren’t possible before. Consequently, the ability to easily modify workflow, templates, etc is vital. Mobile devices: Both patients and doctors have mobile devices wherever they are. DPC practices, as inherently customer focused organizations, naturally want to deliver convenience to their patients. One DPC practice shared how they haven’t seen a patient with shingles in person in years. Instead of the hassle of scheduling an appointment (often taking days to get in), they can take a picture of the symptoms with their mobile device and send it to their doctor right away. Assuming it is shingles, the doctor can call in a prescription and save everyone time and money.Biometric devices: There is an explosion of personal biometric devices. Increasingly, patients are buying them or providers are buying them on behalf of patients with chronic conditions.
Via nrip
|